New cholesterol drug enters early human testing
NCT ID NCT06238466
First seen Sep 30, 2025 · Last updated May 13, 2026 · Updated 29 times
Summary
This early-stage study tests a new drug called AZD1705 in about 98 adults with high cholesterol. The main goal is to check if the drug is safe and how the body processes it. Participants receive either the drug or a placebo as a shot, and researchers monitor side effects and cholesterol levels. This is not a cure but aims to help control cholesterol.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Research Site
Glendale, California, 91206, United States
-
Research Site
Jacksonville, Florida, 32216, United States
-
Research Site
Winter Park, Florida, 32789, United States
-
Research Site
Baltimore, Maryland, 21225, United States
-
Research Site
San Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.